ResMed Inc. (LON:0KW4)
243.34
-2.34 (-0.95%)
At close: May 9, 2025
ResMed Revenue
ResMed had revenue of $1.29B USD in the quarter ending March 31, 2025, with 7.92% growth. This brings the company's revenue in the last twelve months to $5.02B, up 9.54% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.
Revenue (ttm)
$5.02B
Revenue Growth
+9.54%
P/S Ratio
7.07
Revenue / Employee
$503.16K
Employees
9,980
Market Cap
27.49B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
ResMed News
- 10 days ago - Top 15 High-Growth Dividend Stocks To Consider For May 2025 - Seeking Alpha
- 11 days ago - Resmed Acquires VirtuOx - GlobeNewsWire
- 15 days ago - Billion-dollar medical start-ups say Trump could force a US move - The Australian Financial Review
- 17 days ago - We reaffirmed our tariff relief in 2008 and 2009, we went back again 3 weeks ago, says Resmed CEO - CNBC
- 18 days ago - ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast - Benzinga
- 18 days ago - ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast - Benzinga
- 18 days ago - Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday - Benzinga
- 19 days ago - ResMed declares $0.53 dividend - Seeking Alpha